Webdisclosure.com

Search

UCB (EBR:UCB) UCB Media Room: UCB Disposal of own shares

Directive transparence : information réglementée

20/01/2020 20:05
https://u7061146.ct.sendgrid.net/wf/click?upn=3DG62jSYfZdO-2F12d8lSllQBx1W2= 7HkUdGSImvHQ6Hnxecs05XpH0VAHtGVadhymROvccLDuPo4e3shozjfSvwUQShiOx04Vx-2F6lB= 5Gokicr-2FLePeHzwfle6UFxC3Q2C2FJ_-2B-2Ft0TnE1oEbVIWS8vHM8JK8eu8RpJ4re5BwmFR= w6Tr0XlsWOeqQqZTjzwcPKItQR0hTxd9ZQ7rBLYSOuAKeTefElHQ9EZfLoWbvi8z1TsACweuefq= 1j7aLh5rSNYINPQRdwz8v4qdaJiuPUtMPIriH-2BTl29IkUI6oz-2BtLYb3WGIJLHObfRSg0DEm= FDC0lGXGkhKo8IWRODBka2DX9zY5XHyKt3oih1PD3Ao8jg1oqThwWl14VS4rPocfFWWx6cPMG63= DkzzI5ZX527zxYY0aKeebDh8GIxs0403ekMSVSlqWiTx-2FUATF-2BEZsfP6sC-2BDV5obBEO0c= 6nFkfxu6Nbwi4bihc10HJGs6ARSoa3TkPxA-3D ** Disposal of own shares ------------------------------------------------------------ Brussels (Belgium), 20 January 2020 =E2=80=93 20:05 (CET) =E2=80=93 regulat= ed information In application of article 8:6 of the Royal Decree executing the new Belgian= Code of Companies and Associations, UCB SA/NV announces that following exe= rcises of stock options by its employees, it has disposed of UCB shares OTC= in view of deliveries of shares to the relevant employees, within the fram= ework of the Long Term Incentive Program of the UCB Group, as follows: https://u7061146.ct.sendgrid.net/wf/click?upn=3DG62jSYfZdO-2F12d8lSllQBx1W2= 7HkUdGSImvHQ6Hnxecs05XpH0VAHtGVadhymROvMGJHfzw-2BzRvPoumDQMl68nzhXknImK-2FQ= 2cVtlMZvL1IRW7Qtj8VaBrBkuEe9h-2Ff-2B_-2B-2Ft0TnE1oEbVIWS8vHM8JK8eu8RpJ4re5B= wmFRw6Tr0XlsWOeqQqZTjzwcPKItQR0hTxd9ZQ7rBLYSOuAKeTefElHQ9EZfLoWbvi8z1TsACwe= uefq1j7aLh5rSNYINPQRdwz8v4qdaJiuPUtMPIriH-2BTl29IkUI6oz-2BtLYb3WGIJLHObfRSg= 0DEmFDC0lGXGkhKo8IWRODBka2DX9zY5XLrp58hadfP4mZA4-2F2AvONbXOTTVAniQWkKdyLzH3= O9J3TlrIlbRzoF80ckTlWDCwXvyd7D8tteycRiVwyUisxhkO1pCx4hAZqth5C9XMj-2BdtozhSf= v1Oxe95frGEokpAeaPeZiN2i1Co2blLzBSXvc-3D https://u7061146.ct.sendgrid.net/wf/click?upn=3DG62jSYfZdO-2F12d8lSllQBx1W2= 7HkUdGSImvHQ6Hnxecs05XpH0VAHtGVadhymROvIkxDvlZDfUMyE8IjMgMyJenzG-2FgkmdQII2= sJ5ZaMBIpvU-2FTf9dL3E0zwcoEYIkKT_-2B-2Ft0TnE1oEbVIWS8vHM8JK8eu8RpJ4re5BwmFR= w6Tr0XlsWOeqQqZTjzwcPKItQR0hTxd9ZQ7rBLYSOuAKeTefElHQ9EZfLoWbvi8z1TsACweuefq= 1j7aLh5rSNYINPQRdwz8v4qdaJiuPUtMPIriH-2BTl29IkUI6oz-2BtLYb3WGIJLHObfRSg0DEm= FDC0lGXGkhKo8IWRODBka2DX9zY5XH4658L41kRhqJk0OWkDySsfM-2BtI2GRILpfXkVbdd6LFD= 2TeRIDg-2FOM1j0VdusS-2B9GnMXnJAPnP9-2BEJsT3RnhjZlJFE5vbfWQIcrdzq-2F7V1u-2F5= LL5mu0xGsujoeaHDhxnMUx9aLsZ9FWZYErh6Qe54g-3D https://u7061146.ct.sendgrid.net/wf/click?upn=3DG62jSYfZdO-2F12d8lSllQBx1W2= 7HkUdGSImvHQ6Hnxecs05XpH0VAHtGVadhymROvk4urpP5jLE0pYZ-2FvCbIRJ4TXbHUWcText8= utz8G1hWLKp-2FmcSMeGZ28ISEG1te41_-2B-2Ft0TnE1oEbVIWS8vHM8JK8eu8RpJ4re5BwmFR= w6Tr0XlsWOeqQqZTjzwcPKItQR0hTxd9ZQ7rBLYSOuAKeTefElHQ9EZfLoWbvi8z1TsACweuefq= 1j7aLh5rSNYINPQRdwz8v4qdaJiuPUtMPIriH-2BTl29IkUI6oz-2BtLYb3WGIJLHObfRSg0DEm= FDC0lGXGkhKo8IWRODBka2DX9zY5XCAjm8ZE6m-2BvvIanK1zkZqH-2BR2WHWAsnsjnSGcGdwI9= eGWnvS1b5fRWkttv2DMYV8ZD3RyaV9DTuGb2yj0gh-2FFbqsIodMDC5MSSSHjjo1sithJUFviGC= sS1KuxA9tlRIc0nOZtjqniE1B1Dx5SGP03w-3D This press release is available on UCB SA/NV=E2=80=99s website via the foll= owing link (https://u7061146.ct.sendgrid.net/wf/click?upn=3DG62jSYfZdO-2F12= d8lSllQBw8mZTc-2F8qlca0irhLuY1sP8aW71eqg0Fasln-2Bj-2FwWDBwh6d1mAm26jimWNXnH= tH0g-3D-3D_-2B-2Ft0TnE1oEbVIWS8vHM8JK8eu8RpJ4re5BwmFRw6Tr0XlsWOeqQqZTjzwcPK= ItQR0hTxd9ZQ7rBLYSOuAKeTefElHQ9EZfLoWbvi8z1TsACweuefq1j7aLh5rSNYINPQRdwz8v4= qdaJiuPUtMPIriH-2BTl29IkUI6oz-2BtLYb3WGIJLHObfRSg0DEmFDC0lGXGkhKo8IWRODBka2= DX9zY5XF6fAph1XHBwtUgG10e1XD415H9ntwwwKNLJYtnnwNWJ30EtT9GKbQLfoj-2BmR-2FwQa= Bt0BFTs3lQAMscldTjyTLf8b-2FFl1VlQn5saw2tCgc0gkZnlrOPupoJFSNogIkQsEVO-2Bmj9d= lMFgCqMO7HhCUBo-3D . Investor Relations Antje Witte =C2=A0 =C2=A0 =C2=A0 =C2=A0 =C2=A0 Investor Relations, UCB T +32.2.559.94.14 antje.witte@ucb.com Isabelle Ghellynck, =C2=A0Investor Relations, UCB T+32.2.559.9588, isabelle.ghellynck@ucb.com=C2=A0 About UCB UCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company = focused on the discovery and development of innovative medicines and soluti= ons to transform the lives of people living with severe diseases of the imm= une system or of the central nervous system. With 7 500 people in approxima= tely 40 countries, the company generated revenue of =E2=82=AC 4.6 billion i= n 2018. UCB is listed on Euronext Brussels (symbol: UCB). Follow us on Twit= ter: @UCB_news https://u7061146.ct.sendgrid.net/wf/click?upn=3DG62jSYfZdO-2F12d8lSllQB4trS= xvnrPCETdekFatfkGipW8rZPWJwQLSNhWnPeXY-2F7ll2E9JWF7NFU-2B9nVoP5ey8TXt931zuU= M87FYMV3yy4-3D_-2B-2Ft0TnE1oEbVIWS8vHM8JK8eu8RpJ4re5BwmFRw6Tr0XlsWOeqQqZTjz= wcPKItQR0hTxd9ZQ7rBLYSOuAKeTefElHQ9EZfLoWbvi8z1TsACweuefq1j7aLh5rSNYINPQRdw= z8v4qdaJiuPUtMPIriH-2BTl29IkUI6oz-2BtLYb3WGIJLHObfRSg0DEmFDC0lGXGkhKo8IWROD= Bka2DX9zY5XAXnjHtOItBEkd1XOHId8crMXFmHyzS1UOtGdqkPFN9Go42PgfTJhNrek-2B4H0ZO= n3-2F-2F0xFVq6NbV9Rzn9RiVegBw-2BWHk7diXR-2FFAIdRoJv-2BlZQk6qowqHq-2BXHw-2Fn= imGqxYVy8rEkrx6EReJbpVrN6pg-3D Image Capture 1 Disposal of Own Shares Jan 20 (https://u7061146.ct.sendgrid.net/w= f/click?upn=3DG62jSYfZdO-2F12d8lSllQB4trSxvnrPCETdekFatfkGjUxLY2psAdIPMnKIb= DVzLEsveHikueQPe-2Fv3uc3Yl-2BnqoTnpNdkaRjk4iSJxuepbUmtaCXh-2FdHagH2huzThTvV= _-2B-2Ft0TnE1oEbVIWS8vHM8JK8eu8RpJ4re5BwmFRw6Tr0XlsWOeqQqZTjzwcPKItQR0hTxd9= ZQ7rBLYSOuAKeTefElHQ9EZfLoWbvi8z1TsACweuefq1j7aLh5rSNYINPQRdwz8v4qdaJiuPUtM= PIriH-2BTl29IkUI6oz-2BtLYb3WGIJLHObfRSg0DEmFDC0lGXGkhKo8IWRODBka2DX9zY5XI-2= FMUVsUprwiCoDOCS6clrRiIlswjfB5sjMEqc5qEehE1yo8mlaJJCKCrhQiyrucpNjArptgFaEUP= Mqi3PAg6sFRSijwM1NnoTbDdcMxtFY2692HuYPt14bxr62c-2F36yoCVwS1MOgWX6S8WE-2BRgf= Gfw-3D Image Capture 2 Disposal of Own Shares Jan 20 (https://u7061146.ct.sendgrid.net/w= f/click?upn=3DG62jSYfZdO-2F12d8lSllQB4trSxvnrPCETdekFatfkGgqbqdqJJFVg95SShc= j9COOI6CwDI9i-2BN0l0aq0S8njWwFLyeAYB5LmmH5cgT6REoY5u1x-2BUapptfT-2Bs6-2F3WS= PZ_-2B-2Ft0TnE1oEbVIWS8vHM8JK8eu8RpJ4re5BwmFRw6Tr0XlsWOeqQqZTjzwcPKItQR0hTx= d9ZQ7rBLYSOuAKeTefElHQ9EZfLoWbvi8z1TsACweuefq1j7aLh5rSNYINPQRdwz8v4qdaJiuPU= tMPIriH-2BTl29IkUI6oz-2BtLYb3WGIJLHObfRSg0DEmFDC0lGXGkhKo8IWRODBka2DX9zY5XK= fRjNy0qEQwGl-2BWmFH0pI4m2ncUfKCsraU7SQPQ9ANZrHm5zzfacOZRVJKH-2BsqbkOxgLVXKU= WndtFJHZRmz6HJznJDMcGNdoo9cFgGQ93saizgBuYMIaE03PZFCtDcjCmHhkDub3h6KLHHXUlPp= 8Tw-3D Image Capture 3 Disposal of Own Shares Jan 20 (https://u7061146.ct.sendgrid.net/w= f/click?upn=3DG62jSYfZdO-2F12d8lSllQB4trSxvnrPCETdekFatfkGgPXZKvEO-2FAHgBjm= poI2-2FKrhzxDc1naQzJKbFqAXH5AWMZB75NNVFstZQdPNp9ivRaaBgytA9xmwSLxFs3xwU1f_-= 2B-2Ft0TnE1oEbVIWS8vHM8JK8eu8RpJ4re5BwmFRw6Tr0XlsWOeqQqZTjzwcPKItQR0hTxd9ZQ= 7rBLYSOuAKeTefElHQ9EZfLoWbvi8z1TsACweuefq1j7aLh5rSNYINPQRdwz8v4qdaJiuPUtMPI= riH-2BTl29IkUI6oz-2BtLYb3WGIJLHObfRSg0DEmFDC0lGXGkhKo8IWRODBka2DX9zY5XGO-2F= 7RuARPBjYOMk5JhHU7Lre9TcoKyzLSybrddH-2F46HzBDEiq1O1mzn8kGbGQHy7rQVkRkd6PMza= qbIYAWtetuTFQYBYqQTLx4iREP1gmTHIg-2BhAk-2FDiGAX0CXvUE42A98ZbgRxvYIaCiTx7-2F= 3XqDY-3D GenericFile 20100120- Disposal of own shares (https://u7061146.ct.sendgrid.net/wf/click= ?upn=3DG62jSYfZdO-2F12d8lSllQBx1W27HkUdGSImvHQ6Hnxecs05XpH0VAHtGVadhymROvcC= KmSpxDXe5xP9mlyoPKJjYEgT-2ByowDeels69w8XOOY-3D_-2B-2Ft0TnE1oEbVIWS8vHM8JK8e= u8RpJ4re5BwmFRw6Tr0XlsWOeqQqZTjzwcPKItQR0hTxd9ZQ7rBLYSOuAKeTefElHQ9EZfLoWbv= i8z1TsACweuefq1j7aLh5rSNYINPQRdwz8v4qdaJiuPUtMPIriH-2BTl29IkUI6oz-2BtLYb3WG= IJLHObfRSg0DEmFDC0lGXGkhKo8IWRODBka2DX9zY5XP-2FicSZmi2SqgP-2FKoDvyDFyYz-2Bh= yNT5p1-2BkZfOCEW7PwCZ-2Fb8sWnxtRUPZSiavnLuA2FW944owSrDJX2f8k1ffCzVjX7TvTnDY= pKalAPA9OQYm2WkCbozdPGDihMd-2BD9NXUSyYOyK9XlnsuCiJhIzG0-3D GenericFile 20200120 - Ali=C3=A9nation d actions propres (https://u7061146.ct.sendgrid.= net/wf/click?upn=3DG62jSYfZdO-2F12d8lSllQBx1W27HkUdGSImvHQ6Hnxecs05XpH0VAHt= GVadhymROvpBvVe0sk5cBnGesWU8IzoflHVaZEdFqGcvxw-2BN9-2BWww-3D_-2B-2Ft0TnE1oE= bVIWS8vHM8JK8eu8RpJ4re5BwmFRw6Tr0XlsWOeqQqZTjzwcPKItQR0hTxd9ZQ7rBLYSOuAKeTe= fElHQ9EZfLoWbvi8z1TsACweuefq1j7aLh5rSNYINPQRdwz8v4qdaJiuPUtMPIriH-2BTl29IkU= I6oz-2BtLYb3WGIJLHObfRSg0DEmFDC0lGXGkhKo8IWRODBka2DX9zY5XLxMisgW9-2Fae2q1bk= kezN6bJBXIyxuQ0IO2jy0r6OyaWFbmTcm7ivyFvlLlwcnsH4Ay8kYgrgW0dYbEqekgQx2ubKRRG= PFEpnPbD8dKVxcOo6sZia8ZkPkaMgsDxnts3Aq9FlP-2BpQlmdRNSKn1Zcl1I-3D GenericFile 20200120 - Vervreemding van eigen aandelen (https://u7061146.ct.sendgrid.ne= t/wf/click?upn=3DG62jSYfZdO-2F12d8lSllQBx1W27HkUdGSImvHQ6Hnxecs05XpH0VAHtGV= adhymROvvoApcVFFMW7-2BFDuuMSwLZUZF6QZG7ZMSk9VxBLQ-2BMs4-3D_-2B-2Ft0TnE1oEbV= IWS8vHM8JK8eu8RpJ4re5BwmFRw6Tr0XlsWOeqQqZTjzwcPKItQR0hTxd9ZQ7rBLYSOuAKeTefE= lHQ9EZfLoWbvi8z1TsACweuefq1j7aLh5rSNYINPQRdwz8v4qdaJiuPUtMPIriH-2BTl29IkUI6= oz-2BtLYb3WGIJLHObfRSg0DEmFDC0lGXGkhKo8IWRODBka2DX9zY5XGmPnw1S30H-2FIxblDB4= b2yFfHc2t1BwdgAvuZSLI6JJOV-2B9VrhRr3GbBtGeQrqpXaqWeZSawFQugsURT8oXQvobGUWzs= YYYuim4v0B3p-2Be-2BjEkXOHEj2S0YptWcvPYDvZyzbhXDwmVfrVHHfh3BgOaw-3D=0D =0D ______________________=0D If you would rather not receive future communications from UCB SA, please g= o to https://u7061146.ct.sendgrid.net/wf/click?upn=3DG62jSYfZdO-2F12d8lSllQ= Bz2p53T0v-2BoEIvbo6vDi8C-2BOyFzyb6obo-2BzKSgNKq4mrzTnnVvQaDa6s6FX62V-2BAfdD= kj0yiQ4CGUzwgS0wG8X5wf73bE4nwcGcQs35xz53YqAtl6G-2Bz2P-2FoB46x4hobQoz0AHoM2Q= xzVZYZoEHzRwo-3D_-2B-2Ft0TnE1oEbVIWS8vHM8JK8eu8RpJ4re5BwmFRw6Tr0XlsWOeqQqZT= jzwcPKItQR0hTxd9ZQ7rBLYSOuAKeTefElHQ9EZfLoWbvi8z1TsACweuefq1j7aLh5rSNYINPQR= dwz8v4qdaJiuPUtMPIriH-2BTl29IkUI6oz-2BtLYb3WGIJLHObfRSg0DEmFDC0lGXGkhKo8IWR= ODBka2DX9zY5XGBAnlIOWKZXtvbFBAGm39WFr-2FJdCzmKqMcX1VESolpK-2BeRRBCDoaCgQme3= ablJ2g2RXV32Ctf0J5iV8n29F29LrAGXf8ID8n0iLiAnrUTF6yRk8O8vdy-2BZhgjWELcZGoDu0= pllgFlbvGA3PN7OmWLk-3D=0D UCB SA, All=C3=A9e de la Recherche, 60 ., Brussels, . B - 1070 Belgium=

24/02/2020 20:00
20/02/2020 07:00
14/02/2020 20:01
10/02/2020 20:00
31/01/2020 20:01
28/01/2020 07:01
27/01/2020 20:00
20/01/2020 20:10
20/01/2020 20:05
20/01/2020 20:01